Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Exchange Rate Effect (2019 - 2025)

Historic Exchange Rate Effect for Bio (TELA) over the last 7 years, with Q3 2025 value amounting to $104000.0.

  • Bio's Exchange Rate Effect rose 15531.91% to $104000.0 in Q3 2025 from the same period last year, while for Jun 2025 it was -$292000.0, marking a year-over-year decrease of 204666.67%. This contributed to the annual value of $28000.0 for FY2024, which is 8292.68% down from last year.
  • According to the latest figures from Q3 2025, Bio's Exchange Rate Effect is $104000.0, which was up 15531.91% from -$152000.0 recorded in Q2 2025.
  • In the past 5 years, Bio's Exchange Rate Effect ranged from a high of $182000.0 in Q4 2024 and a low of -$188000.0 during Q3 2024
  • For the 5-year period, Bio's Exchange Rate Effect averaged around -$6473.7, with its median value being $1000.0 (2021).
  • Data for Bio's Exchange Rate Effect shows a peak YoY increase of 215000.0% (in 2022) and a maximum YoY decrease of 540000.0% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Bio's Exchange Rate Effect stood at -$2000.0 in 2021, then surged by 2150.0% to $41000.0 in 2022, then tumbled by 65.85% to $14000.0 in 2023, then surged by 1200.0% to $182000.0 in 2024, then plummeted by 42.86% to $104000.0 in 2025.
  • Its Exchange Rate Effect stands at $104000.0 for Q3 2025, versus -$152000.0 for Q2 2025 and -$134000.0 for Q1 2025.